Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2021, Vol. 144, No. 3

Editorial Comment

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 241–243. https://doi.org/10.1159/000509924
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 244–245. https://doi.org/10.1159/000510687
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 246–249. https://doi.org/10.1159/000510770
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 250–251. https://doi.org/10.1159/000511559

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 252–258. https://doi.org/10.1159/000507974
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 259–263. https://doi.org/10.1159/000509923
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 264–274. https://doi.org/10.1159/000508529
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 275–284. https://doi.org/10.1159/000510504
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 285–292. https://doi.org/10.1159/000510112

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 293–296. https://doi.org/10.1159/000508722
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 297–301. https://doi.org/10.1159/000508526
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 302–307. https://doi.org/10.1159/000509768
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 308–313. https://doi.org/10.1159/000509922
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 314–318. https://doi.org/10.1159/000510179
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 319–321. https://doi.org/10.1159/000510591

Brief Communication

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 322–326. https://doi.org/10.1159/000509596
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 327–331. https://doi.org/10.1159/000509968
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 332–336. https://doi.org/10.1159/000510111
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 337–344. https://doi.org/10.1159/000510459
Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 345–349. https://doi.org/10.1159/000510460

Letter to the Editor

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 350–351. https://doi.org/10.1159/000512574

Pharma News

Subject Area: Hematology , Oncology
Acta Haematol (2021) 144 (3): 352–354. https://doi.org/10.1159/000516435
Close Modal

or Create an Account

Close Modal
Close Modal